IBT welcomes a new Head of Pharmaceutical Development and Manufacturing

IBT is glad to welcome in its team Paul Alhadeff as Head of Pharmaceutical Development and Manufacturing. From today, Paul will lead IBT CMC team. He brings great knowledge from his past experience of over two decades in pharmaceutical development from Kabi Vitrum and AstraZeneca namely.

See Who we are here

March 14, 2016